NYSE:DHRDanaher Stock Price, Forecast & News

Danaher's stock was trading at $139.37 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, DHR shares have increased by 19.5% and is now trading at $166.61. View which stocks have been most impacted by Coronavirus.

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Danaher in the last year. There are currently 4 hold ratings and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Danaher.

Danaher is scheduled to release its next quarterly earnings announcement on Thursday, July 16th 2020. View our earnings forecast for Danaher.

Danaher Co. (NYSE:DHR) released its earnings results on Wednesday, May, 6th. The conglomerate reported $1.05 EPS for the quarter, topping the Zacks' consensus estimate of $1.00 by $0.05. The conglomerate had revenue of $4.34 billion for the quarter, compared to analysts' expectations of $4.32 billion. Danaher had a return on equity of 11.52% and a net margin of 16.85%. Danaher's quarterly revenue was up 2.9% compared to the same quarter last year. During the same period in the prior year, the company earned $1.07 earnings per share. View Danaher's earnings history.

Danaher declared a quarterly dividend on Tuesday, May 5th. Stockholders of record on Friday, June 26th will be given a dividend of $0.18 per share on Friday, July 31st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.43%. The ex-dividend date is Thursday, June 25th. View Danaher's dividend history.

Danaher issued an update on its first quarter 2020 Pre-Market earnings guidance on Monday, April, 13th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $5.026-5.026 billion, compared to the consensus revenue estimate of $4.28 billion.

13 Wall Street analysts have issued 12-month target prices for Danaher's stock. Their forecasts range from $136.00 to $190.00. On average, they anticipate Danaher's share price to reach $169.27 in the next twelve months. This suggests a possible upside of 1.6% from the stock's current price. View analysts' price targets for Danaher.

Press coverage about DHR stock has trended somewhat positive this week, InfoTrie Sentiment Analysis reports. The research group rates the sentiment of press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Danaher earned a news sentiment score of 1.2 on InfoTrie's scale. They also assigned media headlines about the conglomerate a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View the latest news aboutDanaher.

Danaher saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 6,600,000 shares, an increase of 5.4% from the April 15th total of 6,260,000 shares. Based on an average trading volume of 3,740,000 shares, the days-to-cover ratio is presently 1.8 days. Currently, 1.1% of the company's shares are sold short. View Danaher's Current Options Chain.

Some companies that are related to Danaher include Roper Technologies (ROP), Fortive (FTV), Keysight Technologies (KEYS), Cognex (CGNX), MKS Instruments (MKSI), Sensata Technologies (ST), Mesa Laboratories (MLAB), Hurco Companies (HURC), Crawford United (CRAWA), Hickok (HICKA), International Isotopes (INIS), Sypris Solutions (SYPR), Clearsign Combustion (CLIR), Electro-Sensors (ELSE) and Schmitt Industries (SMIT). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Danaher investors own include NVIDIA (NVDA), Home Depot (HD), Walt Disney (DIS), Cisco Systems (CSCO), Adobe (ADBE), Johnson & Johnson (JNJ), Alibaba Group (BABA), Intel (INTC), Alphabet (GOOG) and CVS Health (CVS).

Danaher trades on the New York Stock Exchange (NYSE) under the ticker symbol "DHR."

Danaher's stock is owned by a variety of retail and institutional investors. Top institutional investors include Geode Capital Management LLC (1.34%), Aristotle Capital Management LLC (1.03%), Capital International Investors (0.98%), Bank of New York Mellon Corp (0.75%), Parnassus Investments CA (0.70%) and Legal & General Group Plc (0.60%). Company insiders that own Danaher stock include Alan G Spoon, Angela S Lalor, Brian W Ellis, Daniel L Comas, Daniel Raskas, Donald J Ehrlich, Linda P Hefner, Matthew Mcgrew, Mitchell P Rales, Rainer Blair, Robert S Lutz, Thomas Patrick Joyce Jr, Walter G Lohr, William K Daniel and William King. View institutional ownership trends for Danaher.

DHR stock was sold by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., AQR Capital Management LLC, Waddell & Reed Financial Inc., Deutsche Bank AG, Eaton Vance Management, Prudential PLC, Aviva PLC, and Caisse DE Depot ET Placement DU Quebec. Company insiders that have sold Danaher company stock in the last year include Angela S Lalor, Brian W Ellis, Daniel L Comas, Daniel Raskas, Donald J Ehrlich, Linda P Hefner, Matthew Mcgrew, Rainer Blair, Robert S Lutz, Thomas Patrick Joyce Jr, Walter G Lohr, William K Daniel, and William King. View insider buying and selling activity for Danaher.

DHR stock was purchased by a variety of institutional investors in the last quarter, including Fisher Asset Management LLC, Swedbank, Capital International Investors, Swiss National Bank, Two Sigma Advisers LP, APG Asset Management N.V., APG Asset Management N.V., and Pictet Asset Management Ltd.. View insider buying and selling activity for Danaher.

Shares of DHR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of DHR stock can currently be purchased for approximately $166.61.

Danaher has a market capitalization of $116.21 billion and generates $17.91 billion in revenue each year. The conglomerate earns $3.01 billion in net income (profit) each year or $4.42 on an earnings per share basis. Danaher employs 60,000 workers across the globe.

The official website for Danaher is www.danaher.com.

Danaher's mailing address is 2200 PENNSYLVANIA AVE. N.W SUITE 800W, WASHINGTON DC, 20037. The conglomerate can be reached via phone at 202-828-0850 or via email at [email protected]